333415-38-6

333415-38-6 structure

Name: VU0071063
Chemical Name: 7-(4-tert-Butyl-benzyl)-1,3-dimethyl-3,7-dihydro-purine-2,6-dione
CAS Number: 333415-38-6
Molecular Formula: C₁₈H₂₂N₄O₂
Molecular Weight: 326.393
Catalog: Signaling Pathways Membrane Transporter/Ion Channel Potassium Channel
Create Date: 2018-07-12 08:57:38
Modify Date: 2024-04-03 11:26:44
VU0071063 is a potent and specific Kir6.2/SUR1 opener (EC50=7.44 μM) and can be used for investigating Kir6.2/SUR1 expressed in the pancreas and brain. VU0071063 inhibits insulin secretion by inducing hyperpolarization of β-cell membrane potential. VU0071063 chemotype has a very steep structure-activity relationships[1][2].

Name	7-(4-tert-Butyl-benzyl)-1,3-dimethyl-3,7-dihydro-purine-2,6-dione
Synonyms	1H-Purine-2,6-dione, 7-[[4-(1,1-dimethylethyl)phenyl]methyl]-3,7-dihydro-1,3-dimethyl- MFCD02648040 1H-Purine-2,6-dione, 3,7-dihydro-7-(4-tert-butylbenzyl)-1,3-dimethyl- 7-(4-tert-Butyl-benzyl)-1,3-dimethyl-3,7-dihydro-purine-2,6-dione 1,3-Dimethyl-7-[4-(2-methyl-2-propanyl)benzyl]-3,7-dihydro-1H-purine-2,6-dione

Description	VU0071063 is a potent and specific Kir6.2/SUR1 opener (EC50=7.44 μM) and can be used for investigating Kir6.2/SUR1 expressed in the pancreas and brain. VU0071063 inhibits insulin secretion by inducing hyperpolarization of β-cell membrane potential. VU0071063 chemotype has a very steep structure-activity relationships[1][2].
Related Catalog	Research Areas >> Others Research Areas >> Neurological Disease Signaling Pathways >> Membrane Transporter/Ion Channel >> Potassium Channel
Target	EC50: 7.44 μM (Kir6.2/SUR1)[1]
In Vitro	VU0071063 (1 nM~1 mM; HEK-293 cells) dose dependently opens Kir6.2/SUR1. VU0071063 (0~20 μM; isolated cells) inhibits β-Cell excitability in mouse Islets. VU0071063 (10 μM; 1 hour; isolated cells) inhibits glucose-stimulated insulin secretion[1]. VU0071063 dose dependently and reversibly hyperpolarizes the β-cell membrane potential, which, in turn, inhibits glucose-stimulated Ca2+ entry and insulin secretion. The actions of VU0071063 on the β-cell membrane potential are reversed by tolbutamide, and glucose stimulated insulin secretion is unaffected by the inactive analog 34MT, indicating that the effects are mediated through Kir6.2/SUR1[1].
In Vivo	VU0071063 (50 mg/kg; i.p.; 4 hours) leads to a significant increase in blood glucose at 60 minutes[1]. Animal Model: Male C57BL/6 mice (10–12 weeks age) Dosage: 50 mg/kg (Pharmacokinetic analysis) Administration: I.p.; 4 hours Result: led to a significant increase in blood glucose at 60 minutes.
References	[1]. Kharade SV, et al. Structure-Activity Relationships, Pharmacokinetics, and Pharmacodynamics of the Kir6.2/SUR1-Specific Channel Opener VU0071063. J Pharmacol Exp Ther. 2019;370(3):350-359. [2]. Raphemot R, et al. Direct activation of β-cell KATP channels with a novel xanthine derivative. Mol Pharmacol. 2014;85(6):858-865.

Density	1.2±0.1 g/cm3
Boiling Point	507.8±42.0 °C at 760 mmHg
Molecular Formula	C₁₈H₂₂N₄O₂
Molecular Weight	326.393
Flash Point	260.9±27.9 °C
Exact Mass	326.174286
LogP	3.23
Vapour Pressure	0.0±1.3 mmHg at 25°C
Index of Refraction	1.615
Storage condition	2-8°C

RIDADR	NONH for all modes of transport

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

1251672-64-6	118937-13-6
1251676-78-4	1115923-01-7
1115998-91-8	1116045-06-7
1115923-03-9	1115998-92-9
1116045-07-8	1115998-93-0